Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank80
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-698000.00
↑ 95% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-13.97M
Historical baseline
PeriodValueYoY Change
TTM$-698000.00+86.5%
2025$-5.17M-200.8%
2024$-1.72M+66.5%
2023$-5.13M+82.2%
2022$-28.82M-11.0%
2021$-25.96M+8.5%
2020$-28.37M-104.3%
2019$-13.89M+13.3%
2018$-16.02M-14.9%
2017$-13.94M-